BIM
ACRS icon

BlackRock Investment Management’s Aclaris Therapeutics ACRS Stock Holding History

BlackRock Investment Management’s Portfolio ACRS Stock Details ACRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$1.06M Buy
39,133
+4,238
+12% +$108K ﹤0.01% 2664
2016
Q3 		$894K Buy
34,895
+742
+2% +$15.7K ﹤0.01% 2749
2016
Q2 		$631K Buy
34,153
+13,734
+67% +$272K ﹤0.01% 2926
2016
Q1 		$387K Buy
20,419
+446
+2% +$8.52K ﹤0.01% 2992
2015
Q4 		$538K Buy
+19,973
New +$389K ﹤0.01% 2979

Other funds holding ACRS

VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
SMV
Sofinnova Management VIII Menlo Park, California $183M AUM 4.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock Investment Management's ACRS Position: Q4 2016 in Review

BlackRock Investment Management increased its Aclaris Therapeutics (ACRS) stake by 12% in Q4 2016, buying an estimated $108K and bringing the position to 39,133 shares worth $1.06M. The position accounts for ﹤0.01% of the portfolio, ranked #2664.

BlackRock Investment Management first reported a position in ACRS in Q4 2015 and has held it in 5 quarters since. 100 funds tracked by Wall St. Rank hold ACRS as of Q4 2016.

  • BlackRock Investment Management held 39,133 shares of Aclaris Therapeutics worth $1.06M as of Q4 2016.
  • BlackRock Investment Management bought 4,238 Aclaris Therapeutics shares in Q4 2016, an estimated $108K.
  • Aclaris Therapeutics made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #2664 holding.
  • BlackRock Investment Management first reported a position in Aclaris Therapeutics in Q4 2015 and has held it in 5 quarters since.
  • 100 funds tracked by Wall St. Rank held Aclaris Therapeutics as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.